| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02242937 |
| P698 | PubMed publication ID | 7835004 |
| P2093 | author name string | R Gotzen | |
| M Zuber | |||
| I Filler | |||
| P2860 | cites work | Anticentromere antibody and primary pulmonary hypertension | Q71446708 |
| The CREST syndrome: a distinct serologic entity with anticentromere antibodies | Q72080575 | ||
| Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome | Q72611213 | ||
| Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology | Q29618865 | ||
| Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies | Q33553751 | ||
| Anticentromere antibody in primary biliary cirrhosis | Q33553886 | ||
| Serological markers in progressive systemic sclerosis: clinical correlations | Q33554043 | ||
| Raynaud's phenomenon and positive antinuclear antibodies in a malignancy | Q33563176 | ||
| Positive antinuclear antibodies in malignancies | Q33564636 | ||
| Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting | Q33570128 | ||
| Autoantibody to centromere (kinetochore) in scleroderma sera | Q36361012 | ||
| Immunomorphological characterisation of antinuclear antibodies in chronic liver disease | Q37193694 | ||
| Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma). | Q38143555 | ||
| Significance of anticentromere antibody in idiopathic Raynaud's syndrome | Q39295867 | ||
| Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease | Q39312437 | ||
| A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report | Q39358734 | ||
| Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee | Q39513167 | ||
| Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. | Q39633237 | ||
| The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays | Q43764553 | ||
| The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist | Q44088706 | ||
| Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients | Q44824715 | ||
| Prevalence of anticentromere antibody in blood relatives of anticentromere positive patients. | Q52081821 | ||
| Anticentromere antibody is not specific for connective tissue disease with a promising prognosis. | Q54182701 | ||
| THE CLINICAL SIGNIFICANCE OF THE ANTICENTROMERE ANTIBODY | Q59032616 | ||
| Are ACA and Scl 70 antibodies mutually exclusive? | Q67278888 | ||
| Anticentromere antibodies--clinical correlates | Q68102988 | ||
| Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical study | Q68801707 | ||
| Anticentromere antibody in localized scleroderma | Q68910193 | ||
| Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma | Q69735280 | ||
| Drug-induced anticentromere antibody? | Q69739934 | ||
| Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases | Q69871175 | ||
| Anticentromere antibody: an immunological marker of a subset of systemic sclerosis | Q69875349 | ||
| Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis | Q70238267 | ||
| Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants | Q70240365 | ||
| The anticentromere antibody: disease specificity and clinical significance | Q70383558 | ||
| A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-SCL-70-antibodies | Q70489951 | ||
| A long-term longitudinal study of anticentromere antibodies | Q71002241 | ||
| Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis | Q71002244 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 427-432 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Clinical correlation of anticentromere antibodies. | |
| P478 | volume | 13 |
| Q38650673 | Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis |
| Q51201875 | Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis. |
| Q51283677 | Child-onset systemic sclerosis positive for anticentromere antibodies: two Japanese cases. |
| Q34498250 | Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis |
| Q80141033 | Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome |
| Q74368295 | [Immunological diagnosis of scleroderma] |
Search more.